title: Mutually opposite signal modulation by hypothalamic heterodimerization of ghrelin and melanocortin-3 receptors.
abstract: Interaction and cross-talk of G-protein-coupled receptors (GPCRs) are of considerable interest because an increasing number of examples implicate a profound functional and physiological relevance of homo- or hetero-oligomeric GPCRs. The ghrelin (growth hormone secretagogue receptor (GHSR)) and melanocortin-3 (MC3R) receptors are both known to have orexigenic effects on the hypothalamic control of body weight. Because in vitro studies indicate heterodimerization of GHSR and MC3R, we investigated their functional interplay. Combined in situ hybridization and immunohistochemistry indicated that the vast majority of GHSR-expressing neurons in the arcuate nucleus also express MC3R. In vitro coexpression of MC3R and GHSR promoted enhanced melanocortin-induced intracellular cAMP accumulation compared with activation of MC3R in the absence of GHSR. In contrast, agonist-independent basal signaling activity and ghrelin-induced signaling of GHSR were impaired, most likely due to interaction with MC3R. By taking advantage of naturally occurring GHSR mutations and an inverse agonist for GHSR, we demonstrate that the observed enhanced MC3R signaling capability depends directly on the basal activity of GHSR. In conclusion, we demonstrate a paradigm-shifting example of GPCR heterodimerization allowing for mutually opposite functional influence of two hypothalamic receptors controlling body weight. We found that the agonist-independent active conformation of one GPCR can determine the signaling modalities of another receptor in a heterodimer. Our discovery also implies that mutations within one of two interacting receptors might affect both receptors and different pathways simultaneously. These findings uncover mechanisms of important relevance for pharmacological targeting of GPCR in general and hypothalamic body weight regulation in particular.
authors.affiliation: Institute of Experimental Pediatric Endocrinology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
authors.forename: Anne
authors.initials: A
authors.lastname: Rediger
authors.forename: Carolin L
authors.initials: CL
authors.lastname: Piechowski
authors.forename: Chun-Xia
authors.initials: CX
authors.lastname: Yi
authors.forename: Patrick
authors.initials: P
authors.lastname: Tarnow
authors.forename: Rainer
authors.initials: R
authors.lastname: Strotmann
authors.forename: Annette
authors.initials: A
authors.lastname: Grüters
authors.forename: Heiko
authors.initials: H
authors.lastname: Krude
authors.forename: Torsten
authors.initials: T
authors.lastname: Schöneberg
authors.forename: Matthias H
authors.initials: MH
authors.lastname: Tschöp
authors.forename: Gunnar
authors.initials: G
authors.lastname: Kleinau
authors.forename: Heike
authors.initials: H
authors.lastname: Biebermann
mesh_terms: D000818:Animals; D001111:Arcuate Nucleus of Hypothalamus / Q000378:metabolism*; D019556:COS Cells; D002522:Chlorocebus aethiops; D000242:Cyclic AMP / Q000235:genetics / Q000378:metabolism; D005786:Gene Expression Regulation / Q000502:physiology; D054439:Ghrelin / Q000235:genetics / Q000378:metabolism; D057809:HEK293 Cells; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D009154:Mutation; D009419:Nerve Tissue Proteins / Q000819:agonists / Q000235:genetics / Q000378:metabolism*; D009474:Neurons / Q000378:metabolism*; D055503:Protein Multimerization / Q000502:physiology*; D044104:Receptor, Melanocortin, Type 3 / Q000819:agonists / Q000235:genetics / Q000378:metabolism*; D054440:Receptors, Ghrelin / Q000819:agonists / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology*
chemical_list: D054439:Ghrelin; D009419:Nerve Tissue Proteins; D044104:Receptor, Melanocortin, Type 3; D054440:Receptors, Ghrelin; D000242:Cyclic AMP